Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118789913 | 11878991 | 3 | F | 20140911 | 20160823 | 20151230 | 20160830 | EXP | JP-JNJFOC-20150306584 | JANSSEN | 62.00 | YR | A | M | Y | 68.00000 | KG | 20160830 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118789913 | 11878991 | 1 | PS | SOVRIAD | SIMEPREVIR | 1 | Oral | N | 205123 | 100 | MG | CAPSULE | QD | ||||||
118789913 | 11878991 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 400 | MG | UNSPECIFIED | QD | ||||||
118789913 | 11878991 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 600 | MG | UNSPECIFIED | QD | ||||||
118789913 | 11878991 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 800 | MG | UNSPECIFIED | QD | ||||||
118789913 | 11878991 | 5 | SS | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | Y | 0 | 1.25 | UG/KG | INJECTION | /wk | ||||||
118789913 | 11878991 | 6 | SS | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | Y | 0 | 1.5 | UG/KG | INJECTION | /wk | ||||||
118789913 | 11878991 | 7 | SS | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | Y | 0 | .75 | UG/KG | INJECTION | /wk | ||||||
118789913 | 11878991 | 8 | SS | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | Y | 0 | 1.25 | UG/KG | INJECTION | /wk | ||||||
118789913 | 11878991 | 9 | SS | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | Y | 0 | 1.5 | UG/KG | INJECTION | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118789913 | 11878991 | 1 | Chronic hepatitis C |
118789913 | 11878991 | 2 | Chronic hepatitis C |
118789913 | 11878991 | 3 | Chronic hepatitis C |
118789913 | 11878991 | 4 | Chronic hepatitis C |
118789913 | 11878991 | 5 | Chronic hepatitis C |
118789913 | 11878991 | 6 | Chronic hepatitis C |
118789913 | 11878991 | 7 | Chronic hepatitis C |
118789913 | 11878991 | 8 | Chronic hepatitis C |
118789913 | 11878991 | 9 | Chronic hepatitis C |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118789913 | 11878991 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118789913 | 11878991 | Anaemia | |
118789913 | 11878991 | Blood bilirubin increased | |
118789913 | 11878991 | Neutrophil count decreased | |
118789913 | 11878991 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118789913 | 11878991 | 1 | 20140909 | 20141201 | 0 | |
118789913 | 11878991 | 2 | 20141111 | 20141118 | 0 | |
118789913 | 11878991 | 3 | 20141014 | 20141110 | 0 | |
118789913 | 11878991 | 4 | 20140909 | 20141013 | 0 | |
118789913 | 11878991 | 5 | 20141111 | 0 | ||
118789913 | 11878991 | 6 | 20140909 | 20141028 | 0 | |
118789913 | 11878991 | 7 | 20141104 | 20141104 | 0 | |
118789913 | 11878991 | 8 | 20141111 | 0 | ||
118789913 | 11878991 | 9 | 20140909 | 20141028 | 0 |